[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Upstate Institutional Review Board (IRB) Number:

1432147

Study/Protocol ID:

54767414MMY3021

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Teresa C Gentile, MD, PhD

What is involved if I participate?

  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    No

Where will the study take place?

SUNY Upstate Hospital and Cancer Center

ClinicalTrials.Gov ID:

NCT03901963

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Corey Chase
Phone: 315-464-4187
Email: chasec@upstate.edu

Return to Previous Page || Search Again

Top